Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (SPM) (MFR#: DK-1577272925-2016006714) on 30-JUN-2016. Case received from a consumer/other non-health professional via HA on 27-Jun-2016 under the case number DK-DKMA-WBS-0003866. A 12-year-old female adolescent patient received GARDASIL, (batch number NN20940, Dose 1) on 18-Jul-2011, GARDASIL, (batch number G009615, Dose 2) on an unknown date, GARDASIL, (batch number G009615, Dose 3) on 20-May-2012. The patient received concomitant administration of PRIORIX 1DF on 18-Jul-2011. The patient experienced Dizziness, Nausea, Migraine attacks, Pale, Dry eyes, Dry mouth, Slight fever (37.6), Concentration problems, Tiredness, Memory problems / problems with short-term memory, Food aversion, Constant headache, Light sensitivity and School attendance impossible in 8th and 9th grade, she wasn''t admitted to high school due to sick absence on an unknown date. The patient recovered from Slight fever (37.6) in APR-2015. She had not recovered from Dizziness, Nausea, Migraine attacks, Pale, School attendance impossible in 8th and 9th grade, she wasn''t admitted to high school due to sick absence, Tiredness, Memory problems / problems with short-term memory, Food aversion, Constant headache, Concentration problems. Dry eyes, dry mouth and photophobia: recovering. The patient had not been treated for the events. Notes: The adverse events have made going to school impossible in 8th and 9th grades. Which has consequently lead to that she has not been admitted to high school due to absence. She has therefore attended 10th grade at a continuation school. She has concentration problems and problems with short term memory, and the parents are therefore worried that she may not be able to finish high school.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166